The Centers for Medicare and Medicaid Services is repealing a final rule issued in January that would have covered breakthrough technology in Medicare.
The rule that would have allowed access to Food and Drug Administration-designated and -approved technologies for Medicare patients suffering from illnesses and conditions that existing treatments and technologies are unable to address.
CMS repeals rule allowing coverage of breakthrough technologies for Medicare patients
